Vaccine Adjuvants Market Research Report includes various topics like total Market Size, Key Market Drivers, Challenges, Growth Opportunities, Industry Share, Growth, Demand, Outlook etc. Furthermore, it covers key market updates, the impact of regulations and technological updates in.
pune, India - July 5, 2019 /MarketersMedia/ —
Market Overview
A vaccine adjuvant is an immunological agent which aids in the modification of the effect of other agents. A vaccine adjuvant is added to a vaccine to enhance the immune response and enable long-lasting protection against antigens. Many products, chemicals like aluminum phosphate, aluminum hydroxide, and aluminum potassium sulfate are used as adjuvants in the production of vaccines. The current report by Market Research Future (MRFR) claims that the global vaccine adjuvant market is expected to mushroom at 10.1% CAGR during the forecast period of 2017-2023.
Various factors snowballing growth in the global vaccine adjuvants market include the increasing demand for adjuvants for enhancement and extension of immune response and need for the development of non-toxic adjuvants. Furthermore, hefty investments by companies in the research and development, magnifying focus on immunization programs, and the intensifying demand for vaccines are anticipated to promote market growth for vaccine adjuvants. Also, increasing prevalence of diseases in children and a rising number of awareness programs to promote vaccination are estimated to augment market to a great extent. Even though many factors are causative of the positive ascension of the market, the high toxicity of adjuvants and a high cost of developing new vaccine adjuvants are likely to act as market restraints during the forecast period.
Get Sample Report on “Vaccine Adjuvants Market Research Report - Global forecast till 2023” @ https://www.marketresearchfuture.com/sample_request/1098
Key Players and Industry Buzz
Some of the significant market vendors for vaccine adjuvants include
• VaxLiant LLC. (U.S),
• Aphios Corporation (U.S),
• Vaxine Pty Ltd (Australia),
• Agenus, Inc. (U.S),
• Viscogel AB (Sweden),
• Sergeant Adjuvants (U.S),
• Adjuvatis (France),
• Brenntag Biosector (Denmark),
• CureVac AG (Germany),
• Sigma-Aldrich Co. LLC. (India),
• SPI Pharma, Inc (U.S),
• Avanti Polar Lipids, Inc. (U.S),
• SEPPIC (Fracne),
• Novavax, Inc. (U.S),
• MPV Technologies (U.S),
• Invivogen (U.S),
• CSL Limited (Australia)
• OZ Biosciences (France)
May 2019: Biomedical Advanced Research and Development Authority (BARDA) has informed Emergent BioSolutions Inc. will start the procurement of AV7909 (anthrax vaccine adsorbed with CPG 7909 vaccine adjuvant) to provide delivery into the Strategic National Stockpile, according to the announcement made by Emergent BioSolutions Inc.
Detailed Regional Analysis
The global vaccine adjuvants market is segmented, based on region, into the Americas, Europe, Asia Pacific, and the Middle East & Africa. The Americas are further segmented into North America and Latin America. Europe is further segmented into Western Europe and Eastern Europe. Asia Pacific is studied for country-specific markets of China, India, Japan, Australia, Republic of Korea, and Rest of Asia Pacific.
Among the primary regional segments, the Americas are estimated to spearhead the global vaccine adjuvants market. This can be owed to the significant initiatives launched by the government for vaccination against many diseases, coupled with the excellent management of public awareness programs.
Europe is likely to follow the Americas and garner the second largest market for vaccine adjuvants. Such upscaling of the market in the region can be attributed to the increasing emphasis on the research and development of new and enhanced vaccine adjuvants. Further, substantial funds invested in the same are promoting positive ascension of the vaccine adjuvants market. Also, the governments in the region are observed to campaign about the advantages of vaccination and numerous preventive measures against infectious and non-infectious diseases, driving the market exponentially.
Asia Pacific is expected to expand at a relatively higher rate during the forecast period. Governments in several developing economies residing in Asia Pacific have undertaken a significant number of vaccination programs to educate people and create necessary awareness. Within Asia Pacific, India is estimated to emerge as the fastest growing market for vaccine adjuvants. This fast-paced upscaling can be attributed to the rapid population growth in the country and the increasing focus on immunization programs by the government in collaboration with various NGOs.
The market for vaccine adjuvants in the Middle East and Africa is expected to showcase a steady growth through the assessment period. This can be owed to the lower demand for vaccine adjuvants in comparison to other regions across the globe.
Get More Professional and Technical Industry Insights @ https://www.marketresearchfuture.com/reports/vaccine-adjuvants-market-1098
Market Segmentation
The global vaccine adjuvants market is segmented by types, routes of administration, end-users, and region. Based on types, the global vaccine adjuvants market is segmented into particulate adjuvants and pathogen components. Based on routes of administration, the global vaccine adjuvants market is analysed for the segments of intramuscular, oral, intradermal, and subcutaneous. Based on end-users, the market is segmented into paediatric and adult.
Contact Info:
Name: Abhishek
Email: Send Email
Organization: market research future
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune - 411028 Maharashtra, India
Phone: 6468459312
Website: https://www.marketresearchfuture.com/reports/vaccine-adjuvants-market-1098
Source: MarketersMedia
Release ID: 88892981
